TEBRAZID
As listed in the register: TEBRAZID
500 mg · tablet
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Pyrazinamide
- Made by
- Bausch Health, Canada Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Pyrazinamide). It describes the substance, not this exact product.
Pyrazinamide is well absorbed from the GI tract and attains peak plasma concentrations within 2 hours.
Plasma concentrations generally range from 30 to 50 mcg/mL with doses of 20 to 25 mg/kg.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-03-02
Safety of the active substance
From the US prescribing label for the same active substance (Pyrazinamide). It describes the substance, not this exact product.
- Pyrazinamide is contraindicated in persons: with severe hepatic damage. who have shown hypersensitivity to it. with acute gout.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
FranceNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Bausch Health, Canada Inc. |
|---|---|
| Active substance | Pyrazinamide |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 500 mg |
| Form | tablet |
| Classification | J04AK01 · Antibiotics, antivirals and antifungals taken into the body |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Dormant |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 00283991 |
| DPD drug code | 1828 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.